Growth hormone-releasing peptides in the treatment or prevention of atherosclerosis and hypercholesterolemia
US7785567B2 · kind B2 · utility
1Cited by
3References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 21, 2003 |
| Grant date | Aug 31, 2010 |
| Priority date | — |
| Expiry date | Apr 15, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
According to the invention there is provided a method of treatment or prophylaxis of atherosclerosis, hypercholesterolemia or a cardiovascular disease associated with atherosclerosis, which method comprises administration of one or more Growth Hormone Releasing Peptides (GHRPs) to a patient in need of such treatment or prophylaxis. There are also provided methods of reducing blood plasma cholesterol levels, as well as methods of modulating the expression of the scavenger receptor CD36 and genes involved in cellular cholesterol efflux.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.